124 related articles for article (PubMed ID: 38536662)
1. Natural killer group 2D-major histocompatibility complex class I polypeptide-related sequence A activation enhances natural killer cell-mediated immunity against hepatocellular carcinoma: A review.
Arai J; Okumura A; Kato N; Ito K
Hepatol Res; 2024 May; 54(5):420-428. PubMed ID: 38536662
[TBL] [Abstract][Full Text] [Related]
2. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
3. Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma.
Shin SK; Oh S; Chun SK; Ahn MJ; Lee SM; Kim K; Kang H; Lee J; Shin SP; Lee J; Jung YK
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38800890
[TBL] [Abstract][Full Text] [Related]
4. MICA SNPs and the NKG2D system in virus-induced HCC.
Goto K; Kato N
J Gastroenterol; 2015 Mar; 50(3):261-72. PubMed ID: 25270965
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.
Kohga K; Takehara T; Tatsumi T; Ishida H; Miyagi T; Hosui A; Hayashi N
Hepatology; 2010 Apr; 51(4):1264-73. PubMed ID: 20099300
[TBL] [Abstract][Full Text] [Related]
6. An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma.
Mantovani S; Varchetta S; Mele D; Donadon M; Torzilli G; Soldani C; Franceschini B; Porta C; Chiellino S; Pedrazzoli P; Santambrogio R; Barabino M; Cigala C; Piccolo G; Opocher E; Maestri M; Sangiovanni A; Bernuzzi S; Lhospice F; Kraiem M; Mondelli MU; Oliviero B
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266137
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors.
Costa-Garcia M; Rojas JJ; Ramos MD; Barlabé P; Calvo P; Navas J; Alemany R; Moreno R
Cancer Immunol Immunother; 2024 Jan; 73(1):5. PubMed ID: 38180524
[TBL] [Abstract][Full Text] [Related]
8. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
9. Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma.
Tatsumi T; Takehara T
Hepatol Res; 2016 Mar; 46(5):416-22. PubMed ID: 26574168
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ up-regulates major-histocompatibility-complex class I-related chain A expression and enhances major-histocompatibility-complex class I-related chain A-mediated cytolysis of human corneal epithelium by natural killer cells in vitro.
Hong J; Shao T; Sun X; Li G; Xu J
J Interferon Cytokine Res; 2012 Mar; 32(3):115-20. PubMed ID: 22257014
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms.
Bilotta MT; Abruzzese MP; Molfetta R; Scarno G; Fionda C; Zingoni A; Soriani A; Garofalo T; Petrucci MT; Ricciardi MR; Paolini R; Santoni A; Cippitelli M
FASEB J; 2019 Aug; 33(8):9489-9504. PubMed ID: 31125275
[TBL] [Abstract][Full Text] [Related]
12. NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma.
Wang T; Sun F; Wang Y; Jiang J; Pan M; Yuan M; Zhang H; Du X; Hezam K; Song K; Wang M; Zhang J
J Immunother; 2018 Apr; 41(3):109-117. PubMed ID: 29528990
[TBL] [Abstract][Full Text] [Related]
13. MICA polymorphism: biology and importance in cancer.
Chen D; Gyllensten U
Carcinogenesis; 2014 Dec; 35(12):2633-42. PubMed ID: 25330802
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A.
Busche A; Goldmann T; Naumann U; Steinle A; Brandau S
Hum Gene Ther; 2006 Feb; 17(2):135-46. PubMed ID: 16454647
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents.
Kucuk B; Yilmaz E; Cacan E
Mol Biol Rep; 2021 May; 48(5):3999-4008. PubMed ID: 34009568
[TBL] [Abstract][Full Text] [Related]
16. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Front Immunol; 2018; 9():917. PubMed ID: 29867932
[TBL] [Abstract][Full Text] [Related]
17. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma.
Yang FQ; Liu M; Yang FP; Zhang XL; Yang B; Guo CC; Huang JH; Che JP; Yan Y; Zheng JH
Actas Urol Esp; 2014 Apr; 38(3):172-8. PubMed ID: 24461475
[TBL] [Abstract][Full Text] [Related]
18. Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway.
Chen H; Zhidan W; Xia R; Zhaoxia W; Qing J; Qiang G; Haipeng Y; Hengxiao W
Int Immunopharmacol; 2016 Jun; 35():307-314. PubMed ID: 27089390
[TBL] [Abstract][Full Text] [Related]
19. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
[TBL] [Abstract][Full Text] [Related]
20. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
